NCT05508438View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety of the Transfemoral Mitral Valve Repair System in the Treatment of Patients With Moderately Severe and Severe Functional Mitral Regurgitation(FMR) Who Remained Clinically Symptomatic After Guideline-directed Medical Treatment

NANot yet recruitingINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

August 30, 2022

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2027

Conditions

Mitral Valve Insufficiency

Interventions

DEVICE

Transfemoral mitral-valve repair

Trial Locations (1)

Unknown

Structral Heart Disease Center, Fuwai Hospital, Beijing

All Listed Sponsors

lead

Pan Xiangbin

OTHER

NCT05508438 - To Evaluate the Efficacy and Safety of the Transfemoral Mitral Valve Repair System in the Treatment of Patients With Moderately Severe and Severe Functional Mitral Regurgitation(FMR) Who Remained Clinically Symptomatic After Guideline-directed Medical Treatment | Biotech Hunter | Biotech Hunter